The University of Chicago Header Logo

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer.

Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer. Cancer. 2013 Nov 15; 119(22):3992-4002.

View in: PubMed